CLINICAL_TRIALS ClinicalTrials.gov record update

Examining the Ability of HSV2 Therapy to Reduce HIV Target Cell Numbers in the Cervix.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00946556
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:12.106652+00:00
Published At: 2012-03-22T00:00:00+00:00
Record Updated At: 2012-03-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Herpes Simplex Type Two Infection", "HIV Infections"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2012-03-22"
protocolSection.identificationModule.nctId: "NCT00946556"
protocolSection.identificationModule.officialTitle: "Examining the Ability of HSV2 Therapy to Reduce HIV Target Cell Numbers in the Cervix."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.